Rmb Capital Management, LLC Vertex Pharmaceuticals Inc Transaction History

Rmb Capital Management, LLC

$4.3 Billion
Q3 2024

A detailed history of Rmb Capital Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Rmb Capital Management, LLC holds 1,580 shares of VRTX stock, worth $793,871. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,580

Previous 1,509 4.71%

Holding current value

$793,871

Previous $707,000 3.82%

% of portfolio

0.02%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$460.0 - $505.78 $32,660 - $35,910	71 Added 4.71%	1,580 $734,000
Q2 2024 Aug 13, 2024	BUY	$392.81 - $485.53 $125,306 - $154,884	319 Added 26.81%	1,509 $707,000
Q1 2024 May 14, 2024	BUY	$407.69 - $446.08 $4,484 - $4,906	11 Added 0.93%	1,190 $497,000
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $19,208 - $22,998	56 Added 4.99%	1,179 $479,000
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $39,567 - $42,407	117 Added 11.63%	1,123 $390,000
Q2 2023 Aug 11, 2023	BUY	$314.42 - $351.91 $3,458 - $3,871	11 Added 1.11%	1,006 $354,000
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $284,331 - $319,872	995 New	995 $287,000
Q4 2020 Feb 11, 2021	SELL	$207.01 - $276.09 $241,580 - $322,197	-1,167 Closed	0 $0
Q3 2020 Nov 10, 2020	SELL	$255.65 - $303.1 $54,197 - $64,257	-212 Reduced 15.37%	1,167 $318,000
Q2 2020 Aug 05, 2020	BUY	$225.48 - $295.8 $310,936 - $407,908	1,379 New	1,379 $400,000
Q1 2020 May 11, 2020	SELL	$199.77 - $247.81 $1.6 Million - $1.98 Million	-7,994 Reduced 86.92%	1,203 $286,000
Q4 2019 Feb 13, 2020	SELL	$166.71 - $223.91 $1.26 Million - $1.7 Million	-7,587 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$166.23 - $187.09 $1.11 Million - $1.25 Million	-6,685 Reduced 46.84%	7,587 $1.29 Million
Q2 2019 Aug 13, 2019	SELL	$164.61 - $190.37 $136,790 - $158,197	-831 Reduced 5.5%	14,272 $2.62 Million
Q1 2019 May 15, 2019	SELL	$163.73 - $194.7 $984,017 - $1.17 Million	-6,010 Reduced 28.47%	15,103 $2.78 Million
Q4 2018 Feb 13, 2019	BUY	$151.91 - $192.21 $93,728 - $118,593	617 Added 3.01%	21,113 $3.5 Million
Q3 2018 Nov 14, 2018	BUY	$167.73 - $192.74 $844,017 - $969,867	5,032 Added 32.54%	20,496 $3.95 Million
Q2 2018 Aug 13, 2018	SELL	$145.72 - $169.96 $919,201 - $1.07 Million	-6,308 Reduced 28.97%	15,464 $0
Q1 2018 May 14, 2018	BUY	$151.6 - $177.13 $3.3 Million - $3.86 Million	21,772 New	21,772 $3.55 Million

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rmb Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rmb Capital Management, LLC with notifications on news.

Account

Rmb Capital Management, LLC Vertex Pharmaceuticals Inc Transaction History